“TriNetX offers robust query and analytics tools that enable real-time analyses of patient populations which are helping our customers design better protocols, select the right sites and recruit patients faster,” Lars Olof Eriksson, EVP Site and Patient Recruitment at Icon, told Outsourcing-Pharma.com.
Through the combination of resources, Eriksson said the companies will “disrupt the clinical trial design space by unleashing the power of data and apply it in a pragmatic and effective way to overcome complex clinical development challenges.”
To date, Icon has already conducted more than 300 feasibility reviews using TriNetX to analyze patient populations with search criteria across several data points and assess various inclusion and exclusion criteria.
According to the company, each data point in the TriNetX system can then be traced to healthcare organizations who are able to identify individual patients.
As Outsorucing-Pharma.com previously reported, Icon’s patient recruitment capabilities were also strengthened through its acquisition of PMG Research last year.